Larger Dose Reductions of Vancomycin Required in Neonates with Patent Ductus Arteriosus Receiving Indomethacin versus Ibuprofen

Author(s):
Cristea, S.; Allegaert, K.; Falcao, A.C.; Falcao, F.; Silva, R.; Smits, A.; Knibbe, C.A.J. (0000-0001-9893-4415); Krekels, E.H.J. (0000-0001-6006-1567)
Published
2019
Publication type
Article / Letter to editor
NSAIDdose optimizationibuprofenindomethacinpatent ductus arteriosusvancomycin
Date issued
2019-07-25
Language
English
Is part of
Antimicrobial Agents and Chemotherapy (2019), Vol. 63, no. 8, p. e00853
hdl
1887/82147
doi
10.1128/AAC.00853-19